Healthcare

Key data points: The growth forecast = 5.9% annually for the next 7 years. Scroll below to get more insights. This market report covers Trends, opportunity and forecast in PRRS vaccine market to 2031 by type (live vaccines and killed vaccines), application (government tender and market sales), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 5.5% annually for the next 7 years. Scroll below to get more insights. This market report covers Trends, opportunity and forecast in pseudorabies virus vaccine market to 2031 by type (inactivated vaccine, naturally deficient attenuated vaccine, and genetic engineering vaccine), application (government tender and market sales), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 10.5% annually for the next 7 years. Scroll below to get more insights. This market report covers Trends, opportunity and forecast in rabbit hemorrhagic disease vaccine market to 2031 by type (inactivated vaccines, live attenuated vaccines, subunit vaccines, and DNA vaccines), application (veterinary clinics, research institutions, animal farms, and pharmaceutical companies), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 5.1% annually for the next 7 years. Scroll below to get more insights. This market report covers Trends, opportunity and forecast in swine parvovirus disease vaccine market to 2031 by type (<107.0 tcid50/ml and ≥107.0 tcid50/ml), application (sows and boars), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 17.4% annually for the next 7 years. Scroll below to get more insights. This market report covers Trends, opportunity and forecast in typhoid vi polysaccharide vaccine market to 2031 by type (child and adult), application (government institution, private sector, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 5.9% annually for the next 7 years. Scroll below to get more insights. This market report covers Trends, opportunity and forecast in zika vaccine market to 2031 by type (therapeutic vaccines and preventive vaccines), application (hospitals, clinics, ambulatory surgery centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 5.5% annually for the next 7 years. Scroll below to get more insights. This market report covers trends, opportunities and forecasts in sildenafil drug market to 2031 by type (25mg, 50mg, and 100mg), application (hospital pharmacies, retail pharmacies, and online pharmacies), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 11.2% annually for the next 7 years. Scroll below to get more insights. This market report covers trends, opportunities and forecasts in regenerative injection market to 2031 by type (PLLA injection and PCL injection), application (specialty & dermatology clinics, hospitals, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 7.6% annually for the next 7 years. Scroll below to get more insights. This market report covers trends, opportunities and forecasts in multivalent influenza vaccine market to 2031 by type (trivalent inactivated influenza vaccine (IIV3), trivalent live attenuated vaccine (LAIV3), and quadrivalent inactivated influenza vaccine (IIV4)), application (6 months to 3 years and above 3 years), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 3.4% annually for the next 7 years. Scroll below to get more insights. This market report covers trends, opportunities and forecasts in sulfonylurea hypoglycemic drug market to 2031 by type (first generation sulfonylureas, second generation sulfonylureas, and third generation sulfonylureas), application (hospital, clinic, pharmacy, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 4.4% annually for the next 7 years. Scroll below to get more insights. This market report covers trends, opportunities and forecasts in lamivudine API market to 2031 by type (USP grade, EP grade, and both), application (tablet and oral solution), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 4.5% annually for the next 7 years. Scroll below to get more insights. This market report covers trends, opportunities and forecasts in ganirelix market to 2031 by type (original drugs and generic drugs), application (hospital, pharmacy, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 11.7% annually for the next 7 years. Scroll below to get more insights. This market report covers trends, opportunities and forecasts in antitumor peptide drug market to 2031 by type (lanreotide, octreotide, goserelin, leuprolide, and degarelix), application (hospital, clinic, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 5.5% annually for the next 7 years. Scroll below to get more insights. This market report covers Trends, opportunity and forecast in protecting unnatural amino acid market to 2031 by type (FMOC, BOC, and others), application (drug, cosmetics, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 9.4% annually for the next 7 years. Scroll below to get more insights. This market report covers Trends, opportunity and forecast in D-desthiobiotin market to 2031 by type (purity: less than 95%, purity: 95-97%, and purity: above 97%), application (protein chromatography, protein & cell labeling, detection & isolation, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 23.5% annually for the next 7 years. Scroll below to get more insights. This market report covers Trends, opportunity and forecast in oral acetylcysteine market to 2031 by type (granule for oral solution, capsule, and others), application (medicine, nutritional supplements, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 5.5% annually for the next 7 years. Scroll below to get more insights. This market report covers Trends, opportunity and forecast in comparator drug sourcing market to 2031 by type (local sourcing, central sourcing, and others), application (drug producers/manufacturers, CMO, academic & research institute, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 8.9% annually for the next 7 years. Scroll below to get more insights. This market report covers Trends, opportunity and forecast in chronic spontaneous urticaria drug treatment market to 2031 by type (antihistamine, dupixent, and other), application (children and adult), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 15.7% annually for the next 7 years. Scroll below to get more insights. This market report covers trends, opportunities and forecasts in empagliflozin drug market to 2031 by type (single-ingredient and combination), application (hospitals, retail pharmacy, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 10.3% annually for the next 7 years. Scroll below to get more insights. This market report covers trends, opportunities and forecasts in dupilumab drug market to 2031 by type (200mg (1.14ml)/vial and 300mg (2.0 ml)/vial), application (hospitals, retail pharmacy, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 4.1% annually for the next 7 years. Scroll below to get more insights. This market report covers trends, opportunities and forecasts in cutaneous leishmaniasis drug market to 2031 by type (pentavalent antimonials, antifungal drugs, and anti-leishmanial/antimicrobial drugs), application (hospital, retail pharmacy, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 7.9% annually for the next 7 years. Scroll below to get more insights. This market report covers Trends, opportunity and forecast in nasal injection of vaccine market to 2031 by type (child nasal spray vaccine and adult nasal spray vaccine), application (child and adult), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 8.8% annually for the next 7 years. Scroll below to get more insights. This market report covers Trends, opportunity and forecast in HPMC hollow capsule market to 2031 by type (000# HPMC capsules, 00# HPMC capsules, 0# HPMC capsules, 1# HPMC capsules, 2# HPMC capsules, 3# HPMC capsules, 4# HPMC capsules, and 5# HPMC capsules), application (drug, health products, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 5.1% annually for the next 7 years. Scroll below to get more insights. This market report covers trends, opportunities and forecasts in aripiprazole drug market to 2031 by type (tablets, injection, and others), application (adult patients and pediatric patients), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 12.1% annually for the next 7 years. Scroll below to get more insights. This market report covers Trends, opportunity and forecast in radiolabelled ADME studies market to 2031 by type (C-14, H-3, and others), application (biopharmaceutical companies, government and academic institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 8.1% annually for the next 7 years. Scroll below to get more insights. This market report covers Trends, opportunity and forecast in IHC primary antibodies market to 2031 by type (IGG class, monoclonal, and polyclonal), application (cosmetics, medicine, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 4.9% annually for the next 7 years. Scroll below to get more insights. This market report covers Trends, opportunity and forecast in drugstore chain retail solutions market to 2031 by type (chinese drug, chinese and western drug, and others), application (online e-pharmacy and offline physical pharmacy), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 5.6% annually for the next 7 years. Scroll below to get more insights. This market report covers trends, opportunities and forecasts in hypogonadism drug market to 2031 by type (injections and capsules), application (hospital, pharmacy, specialist clinic, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 11.2% annually for the next 7 years. Scroll below to get more insights. This market report covers Trends, opportunities and forecasts in gynecological progestin drug market to 2031 by type (progesterone, dydrogesterone, and others), application (hospital pharmacies, retail pharmacies, and online pharmacies), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 5.5% annually for the next 7 years. Scroll below to get more insights. This market report covers Trends, opportunities and forecasts in estrogen blocker market to 2031 by type (thyroxin promoter, cortisol inhibitor, and aromatase inhibitor), application (gym, hospital, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 17.3% annually for the next 7 years. Scroll below to get more insights. This market report covers trends, opportunities and forecasts in cyclosporine drug market to 2031 by type (oral and parenteral), application (transplant rejection prophylaxis, rheumatoid arthritis, psoriasis, dry eye, autoimmune myasthenia gravis, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 4.9% annually for the next 7 years. Scroll below to get more insights. This market report covers trends, opportunities and forecasts in short acting nicotine replacement therapy market to 2031 by type (nicotine gum, nicotine lozenge, nasal spray, oral inhaler, and nicotine pouches), application (online sales and offline sales), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 11.3% annually for the next 7 years. Scroll below to get more insights. This market report covers trends, opportunities and forecasts in liposome injection market to 2031 by type (doxorubicin hydrochloride liposome injections, mitoxantrone hydrochloride liposome injections, irinotecan hydrochloride liposome injections, and others), application (malignant tumor treatment, infection treatment, post-operative pain relief, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 7.2% annually for the next 7 years. Scroll below to get more insights. This market report covers Trends, opportunities and forecasts in medical sodium selenite market to 2031 by type (powder and crystallization), application (pharmaceutical and daily chemical), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 11.5% annually for the next 7 years. Scroll below to get more insights. This market report covers trends, opportunities and forecasts in pet recombinant vaccine market to 2031 by type (genetically engineered vaccines, genetically recombinant vaccines, transgenic plant vaccines, and dna vaccines), application (dog, cat, dird, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 0.038 annually for the next 7 years. Scroll below to get more insights. This market report covers Trends, opportunities and forecasts in herpes infection treatment market to 2031 by type (oral, injection, and others), application (hospital, clinic, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 0.038 annually for the next 7 years. Scroll below to get more insights. This market report covers Trends, opportunities and forecasts in crohn's disease treatment drug market to 2031 by type (aminosalicylates, corticosteroids, immunomodulators, and antibiotics), application (small intestine and large intestine), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 0.081 annually for the next 7 years. Scroll below to get more insights. This market report covers Trends, opportunities and forecasts in fluorodeoxyglucose market to 2031 by type (18f-2 and 18f), application (medical imaging and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 0.059 annually for the next 7 years. Scroll below to get more insights. This market report covers Trends, opportunities and forecasts in cough variant asthma (cva) treatment drug market to 2031 by type (bronchodilators, leukotriene antagonists, mast cell stabilizers, corticosteroids, and monoclonal antibody), application (hospital, clinic, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 0.039 annually for the next 7 years. Scroll below to get more insights. This market report covers Trends, opportunities and forecasts in castration-resistant prostate cancer drug market to 2031 by type (oral, intravenous injection, and others), application (hospital, specialty clinic, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 0.043 annually for the next 7 years. Scroll below to get more insights. This market report covers Trends, opportunities and forecasts in urinary incontinence drug market to 2031 by type (antispasmodic agents, skeletal muscle relaxants, alpha blockers, and others), application (hospital pharmacies, retail pharmacies, and online pharmacies), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 6.2% annually for the next 7 years. Scroll below to get more insights. This market report covers Trends, opportunities and forecasts in methane mitigation vaccine market to 2031 by type (vaccines targeting methane-producing archaea and vaccines modulating immune responses), application (cattle, sheep, and others ruminant), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 5.5% annually for the next 7 years. Scroll below to get more insights. This market report covers Trends, opportunities and forecasts in quit smoking chewing gum market to 2031 by type (2 mg nicotine gum, 4 mg nicotine gum, and 6 mg nicotine gum), application (online sales and offline sales), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 6.8% annually for the next 7 years. Scroll below to get more insights. This market report covers Trends, opportunities and forecasts in linagliptin DPP-4 inhibitor market to 2031 by type (original drug and generic drug), application (hospital and retail pharmacy), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 6.9% annually for the next 7 years. Scroll below to get more insights. This market report covers Trends, opportunities and forecasts in covid-19 antigen self test market to 2031 by type (1 serving, 25 servings, and others), application (online and offline), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 12.3% annually for the next 7 years. Scroll below to get more insights. This market report covers Trends, opportunities and forecasts in alzheimer drug market to 2031 by type (aducanumab, donepezil, rivastigmine, memantine, and others), application (mild alzheimer, moderate alzheimer, and severe alzheimer), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 5.0% annually for the next 7 years. Scroll below to get more insights. This market report covers Trends, opportunities and forecasts in onychomycosis drug market to 2031 by type (oral medicine and external medicine), application (hospital pharmacies, retail pharmacies, and online pharmacies), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 5.5% annually for the next 7 years. Scroll below to get more insights. This market report covers Trends, opportunities and forecasts in soliris (eculizumab) market to 2031 by type (plasma exchange and plasma infusion), application (PNH, aHUS, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 4% annually for the next 7 years. Scroll below to get more insights. This market report covers Trends, opportunities and forecasts in furosemide oral solution market to 2031 by type (original drug and generic drug), application (hospital, clinic, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 3.4% annually for the next 7 years. Scroll below to get more insights. This market report covers Trends, opportunities and forecasts in propofol drug market to 2031 by type (10 mL, 20 mL, 50 mL, and 100 mL), application (general anesthesia, medical procedures sedation, mechanical ventilation, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)